Skip to content

Zymeworks ZYME Increase Decrease In Accrued Income Taxes Payable

Increase Decrease In Accrued Income Taxes Payable at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$4.97M-12.7%
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's increase decrease in accrued income taxes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's increase decrease in accrued income taxes payable?
Zymeworks (ZYME) reported increase decrease in accrued income taxes payable of -$16K in Q1 2026.
How has Zymeworks's increase decrease in accrued income taxes payable changed year-over-year?
Zymeworks's increase decrease in accrued income taxes payable decreased by 1500.0% year-over-year, from -$1K to -$16K.
What does increase decrease in accrued income taxes payable mean?
Measures the net change in tax obligations that have been incurred but not yet paid to tax authorities. Fluctuations reflect the timing of tax payments and changes in the company's overall tax liability position.